US Patent Issued to University Of Utah Research Foundation on Aug. 11 for "Methods for producing chemoembolic agents for the delivery of anti-cancer agents" (Utah Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,674, issued on Aug. 11, was assigned to University Of Utah Research Foundation (Salt Lake City).

"Methods for producing chemoembolic agents for the delivery of anti-cancer agents" was invented by Hamid Ghandehari (Salt Lake City), Joseph Cappello (Salt Lake City), Azadeh Poursaid (Salt Lake City) and Mark Martin Jensen (Salt Lake City).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are chemoembolic compositions and agents. The compositions include one or more anti-cancer agents and a silk-elastinlike protein polymer, wherein the compositions are liquids prior to administration to a subject but convert to hydrogels upon administration...